News

The sequential use of immune-modulating medications to treat multiple sclerosis (MS), an inflammatory disease that affects the brain and spinal cord, triggered atypical hemolytic uremic syndrome (aHUS) in a 48-year-old woman, according to a case study. This case highlights “the importance of continuous clinical and laboratory monitoring in…

A woman with atypical hemolytic uremic syndrome (aHUS) developed severe complications affecting the kidneys, brain, and heart, but recovered without lasting neurological damage after prompt treatment that included the complement blocker Soliris (eculizumab), a study showed. The complement cascade is a part of the immune system that is…

Rapid response to treatment was associated with better outcomes among adults with biopsy-confirmed thrombotic microangiopathy (TMA), a group of conditions that includes atypical hemolytic uremic syndrome (aHUS), a small study suggested. “These findings highlight the potential importance of timely recognition and close monitoring of treatment response in patients with…

One year of treatment with Elizaria — a drug similar to the U.S.-approved therapy Soliris (eculizumab) — for atypical hemolytic uremic syndrome (aHUS) was found to be safe and to help stabilize kidney function among people with the genetic disease taking part in a study in Russia. The results…

Treatment with Ultomiris (ravulizumab) successfully prevented disease recurrence in a middle-aged man whose atypical hemolytic uremic syndrome (aHUS) was linked to a novel mutation — one believed to put him at a high risk for relapse — in the CFH gene, a case report from Japan shows. During the…

Ultomiris (ravulizumab) is a safe and effective way to prevent disease recurrence in people with atypical hemolytic uremic syndrome (aHUS) who undergo a kidney transplant, a real-world study in Spain shows. Data from 68 adult patients found that six months of treatment led to significant improvements in blood…

Starting treatment with Ultomiris (ravulizumab) led to rapid clinical improvement — with recovery of kidney function — for a young man with a history of kidney transplant who developed atypical hemolytic uremic syndrome (aHUS) after a severe viral lung infection. According to a report detailing the case, the…

Acute inflammation of the pancreas, or pancreatitis, induced by alcohol abuse triggered atypical hemolytic uremic syndrome (aHUS) in a 43-year-old man, a team of U.S. researchers reported. The man, with a history of alcohol abuse, sought medical attention due to abdominal pain and nausea and was found to have pancreatitis.

Children and adults in the Netherlands with atypical hemolytic uremic syndrome (aHUS) experience differences in clinical presentation and outcomes despite carrying the same disease-linked genetic variant, according to a new study. Children with this variant presented with more profound blood cell abnormalities but milder kidney impairment than adult patients.

Two brothers carrying identical genetic variants associated with atypical hemolytic uremic syndrome (aHUS) and hereditary thrombotic thrombocytopenic purpura (TTP) developed different disease manifestations, as reported in a case series. TTP is a blood disorder, like aHUS, characterized by thrombotic microangiopathy (TMA), in which blood clots form in tiny…